한글목차

의료용 폴리카보네이트 세계 시장 규모는 2024년에 17억 4,900만 달러로 평가되었고, 2025년부터 2031년 예측 기간 동안 CAGR 8.3%로 성장하고 2031년까지 31억 600만 달러로 확대될 것으로 예측되고 있습니다.

본 보고서는 의료용 폴리카보네이트에 대한 최근 관세조정과 국제적 전략적 대책에 대한 국경을 넘나드는 산업 활동, 자본배분 패턴, 지역경제의 상호의존성, 공급망의 재구축을 종합적으로 평가합니다.

폴리카보네이트(PC)는 오늘날 의료기기 산업에서 가장 널리 사용되고 가장 널리 테스트되는 엔지니어링 열가소성 플라스틱 재료 중 하나입니다. 독특한 강도, 우수한 광학 투명성, 높은 열 변형 온도 및 치수 안정성은 까다로운 중요한 의료 용도에 이상적인 재료 선택입니다. 이 보고서는 의료 용도에 사용되는 폴리카보네이트에 중점을 둡니다.

주요 동향

1. 기술 개발

비포스겐 방법으로 제조된 제품은 명백한 가격 이점을 가지고 있습니다. 향후 몇 년간의 생산 능력 확대에 있어서 비포스겐법이 시장 점유율의 대부분을 차지할 전망입니다.

2. 의료 수요는 계속 견고

유행의 영향으로 의료 분야에서 PC 수지에 대한 수요가 지속적으로 늘어나고 있습니다. 현시점에서는 세계적인 유행 억제에 현저한 효과는 보이지 않고, 의료 분야에 있어서의 강한 수요는 앞으로도 일정 기간 계속할 전망입니다.

3. 환경에 배려한 원료

시장에는 생분해성 원료를 이용한 PC제품을 제조하는 대기업이 복수 존재하고 있습니다. 현재 생산량은 그다지 많지 않지만 향후 성장 분야가 될 수 있습니다.

본 보고서는 의료용 폴리카보네이트 세계 시장에 대한 총 판매 수량, 매출, 가격, 주요 기업의 시장 점유율과 순위에 초점을 맞추어 지역·국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 하고 있습니다.

의료용 폴리카보네이트 시장 규모, 추정치, 예측치는 판매량(천톤) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준연도로 하고, 2020년부터 2031년까지의 기간에 있어서의 과거 데이터와 예측 데이터를 포함합니다. 정량적, 정성적 분석 양면으로부터, 독자 여러분이 의료용 폴리카보네이트에 관한 사업 전략, 성장 전략의 책정, 시장 경쟁 평가, 현재의 마켓플레이스에 있어서의 자사의 위치 지정의 분석, 정보에 근거한 사업 판단을 실시하는 것을 지원합니다.

시장 세분화

기업별

• Teijin Limited
• Sinopec
• Covestro
• SABIC
• Mitsubishi
• Trinseo
• Lotte Chemical
• Luxi Chemical
• Wanhua Chemical

유형별 부문

• 포스겐 유형
• 비포스겐 유형

용도별 부문

• 안면 보호 제품
• 주사 및 약물 전달 시스템
• 혈액 여과 및 인공 폐
• 기타

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동 및 아프리카

영문목차

The global market for Polycarbonate for Medical Use was estimated to be worth US$ 1749 million in 2024 and is forecast to a readjusted size of US$ 3106 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Polycarbonate for Medical Use cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Polycarbonate (PC) is one of the engineering thermoplastic materials most commonly used and most widely tested in the medical device industry today. Its inherent strength, excellent optical clarity, high heat distortion temperature, and dimensional stability make it an ideal material choice for demanding, critical healthcare applications. This report focuses on Polycarbonate used for medical use.

Key Trends

1. Technological development

Products produced by non-phosgene method have obvious price advantages. In the release of production capacity in the next few years, the non-phosgene method occupies most of the market share

2. Medical demand will remain strong

Affected by the epidemic, the demand for PC resin in the medical field has been growing strongly. At present, the global control of the epidemic has not shown any significant benefits. Therefore, the strong demand in the medical field will continue for some time in the future.

3. Environmentally friendly raw materials

There are several large companies on the market that use biodegradable raw materials to produce PC products. The current amount is not very large, and the big future may be a development direction.

This report aims to provide a comprehensive presentation of the global market for Polycarbonate for Medical Use, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polycarbonate for Medical Use by region & country, by Type, and by Application.

The Polycarbonate for Medical Use market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polycarbonate for Medical Use.

Market Segmentation

By Company

• Teijin Limited
• Sinopec
• Covestro
• SABIC
• Mitsubishi
• Trinseo
• Lotte Chemical
• Luxi Chemical
• Wanhua Chemical

Segment by Type

• Phosgene type
• Non-Phosgene type

Segment by Application

• Face Protection Products
• Injection and Drug Delivery System
• Blood Filtration and Oxygenator
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Polycarbonate for Medical Use manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Polycarbonate for Medical Use in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Polycarbonate for Medical Use in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Polycarbonate for Medical Use Product Introduction
• 1.2 Global Polycarbonate for Medical Use Market Size Forecast
  • 1.2.1 Global Polycarbonate for Medical Use Sales Value (2020-2031)
  • 1.2.2 Global Polycarbonate for Medical Use Sales Volume (2020-2031)
  • 1.2.3 Global Polycarbonate for Medical Use Sales Price (2020-2031)
• 1.3 Polycarbonate for Medical Use Market Trends & Drivers
  • 1.3.1 Polycarbonate for Medical Use Industry Trends
  • 1.3.2 Polycarbonate for Medical Use Market Drivers & Opportunity
  • 1.3.3 Polycarbonate for Medical Use Market Challenges
  • 1.3.4 Polycarbonate for Medical Use Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Polycarbonate for Medical Use Players Revenue Ranking (2024)
• 2.2 Global Polycarbonate for Medical Use Revenue by Company (2020-2025)
• 2.3 Global Polycarbonate for Medical Use Players Sales Volume Ranking (2024)
• 2.4 Global Polycarbonate for Medical Use Sales Volume by Company Players (2020-2025)
• 2.5 Global Polycarbonate for Medical Use Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Polycarbonate for Medical Use Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Polycarbonate for Medical Use Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Polycarbonate for Medical Use
• 2.9 Polycarbonate for Medical Use Market Competitive Analysis
  • 2.9.1 Polycarbonate for Medical Use Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Polycarbonate for Medical Use Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycarbonate for Medical Use as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Phosgene type
  • 3.1.2 Non-Phosgene type
• 3.2 Global Polycarbonate for Medical Use Sales Value by Type
  • 3.2.1 Global Polycarbonate for Medical Use Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Polycarbonate for Medical Use Sales Value, by Type (2020-2031)
  • 3.2.3 Global Polycarbonate for Medical Use Sales Value, by Type (%) (2020-2031)
• 3.3 Global Polycarbonate for Medical Use Sales Volume by Type
  • 3.3.1 Global Polycarbonate for Medical Use Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Polycarbonate for Medical Use Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Polycarbonate for Medical Use Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Polycarbonate for Medical Use Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Face Protection Products
  • 4.1.2 Injection and Drug Delivery System
  • 4.1.3 Blood Filtration and Oxygenator
  • 4.1.4 Others
• 4.2 Global Polycarbonate for Medical Use Sales Value by Application
  • 4.2.1 Global Polycarbonate for Medical Use Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Polycarbonate for Medical Use Sales Value, by Application (2020-2031)
  • 4.2.3 Global Polycarbonate for Medical Use Sales Value, by Application (%) (2020-2031)
• 4.3 Global Polycarbonate for Medical Use Sales Volume by Application
  • 4.3.1 Global Polycarbonate for Medical Use Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Polycarbonate for Medical Use Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Polycarbonate for Medical Use Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Polycarbonate for Medical Use Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Polycarbonate for Medical Use Sales Value by Region
  • 5.1.1 Global Polycarbonate for Medical Use Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Polycarbonate for Medical Use Sales Value by Region (2020-2025)
  • 5.1.3 Global Polycarbonate for Medical Use Sales Value by Region (2026-2031)
  • 5.1.4 Global Polycarbonate for Medical Use Sales Value by Region (%), (2020-2031)
• 5.2 Global Polycarbonate for Medical Use Sales Volume by Region
  • 5.2.1 Global Polycarbonate for Medical Use Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Polycarbonate for Medical Use Sales Volume by Region (2020-2025)
  • 5.2.3 Global Polycarbonate for Medical Use Sales Volume by Region (2026-2031)
  • 5.2.4 Global Polycarbonate for Medical Use Sales Volume by Region (%), (2020-2031)
• 5.3 Global Polycarbonate for Medical Use Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Polycarbonate for Medical Use Sales Value, 2020-2031
  • 5.4.2 North America Polycarbonate for Medical Use Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Polycarbonate for Medical Use Sales Value, 2020-2031
  • 5.5.2 Europe Polycarbonate for Medical Use Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Polycarbonate for Medical Use Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Polycarbonate for Medical Use Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Polycarbonate for Medical Use Sales Value, 2020-2031
  • 5.7.2 South America Polycarbonate for Medical Use Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Polycarbonate for Medical Use Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Polycarbonate for Medical Use Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Polycarbonate for Medical Use Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Polycarbonate for Medical Use Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Polycarbonate for Medical Use Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Polycarbonate for Medical Use Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Polycarbonate for Medical Use Sales Value, 2020-2031
  • 6.3.2 United States Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Polycarbonate for Medical Use Sales Value, 2020-2031
  • 6.4.2 Europe Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Polycarbonate for Medical Use Sales Value, 2020-2031
  • 6.5.2 China Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Polycarbonate for Medical Use Sales Value, 2020-2031
  • 6.6.2 Japan Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Polycarbonate for Medical Use Sales Value, 2020-2031
  • 6.7.2 South Korea Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Polycarbonate for Medical Use Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Polycarbonate for Medical Use Sales Value, 2020-2031
  • 6.9.2 India Polycarbonate for Medical Use Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Polycarbonate for Medical Use Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Teijin Limited
  • 7.1.1 Teijin Limited Company Information
  • 7.1.2 Teijin Limited Introduction and Business Overview
  • 7.1.3 Teijin Limited Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Teijin Limited Polycarbonate for Medical Use Product Offerings
  • 7.1.5 Teijin Limited Recent Development
• 7.2 Sinopec
  • 7.2.1 Sinopec Company Information
  • 7.2.2 Sinopec Introduction and Business Overview
  • 7.2.3 Sinopec Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Sinopec Polycarbonate for Medical Use Product Offerings
  • 7.2.5 Sinopec Recent Development
• 7.3 Covestro
  • 7.3.1 Covestro Company Information
  • 7.3.2 Covestro Introduction and Business Overview
  • 7.3.3 Covestro Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Covestro Polycarbonate for Medical Use Product Offerings
  • 7.3.5 Covestro Recent Development
• 7.4 SABIC
  • 7.4.1 SABIC Company Information
  • 7.4.2 SABIC Introduction and Business Overview
  • 7.4.3 SABIC Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 SABIC Polycarbonate for Medical Use Product Offerings
  • 7.4.5 SABIC Recent Development
• 7.5 Mitsubishi
  • 7.5.1 Mitsubishi Company Information
  • 7.5.2 Mitsubishi Introduction and Business Overview
  • 7.5.3 Mitsubishi Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Mitsubishi Polycarbonate for Medical Use Product Offerings
  • 7.5.5 Mitsubishi Recent Development
• 7.6 Trinseo
  • 7.6.1 Trinseo Company Information
  • 7.6.2 Trinseo Introduction and Business Overview
  • 7.6.3 Trinseo Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Trinseo Polycarbonate for Medical Use Product Offerings
  • 7.6.5 Trinseo Recent Development
• 7.7 Lotte Chemical
  • 7.7.1 Lotte Chemical Company Information
  • 7.7.2 Lotte Chemical Introduction and Business Overview
  • 7.7.3 Lotte Chemical Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Lotte Chemical Polycarbonate for Medical Use Product Offerings
  • 7.7.5 Lotte Chemical Recent Development
• 7.8 Luxi Chemical
  • 7.8.1 Luxi Chemical Company Information
  • 7.8.2 Luxi Chemical Introduction and Business Overview
  • 7.8.3 Luxi Chemical Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Luxi Chemical Polycarbonate for Medical Use Product Offerings
  • 7.8.5 Luxi Chemical Recent Development
• 7.9 Wanhua Chemical
  • 7.9.1 Wanhua Chemical Company Information
  • 7.9.2 Wanhua Chemical Introduction and Business Overview
  • 7.9.3 Wanhua Chemical Polycarbonate for Medical Use Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Wanhua Chemical Polycarbonate for Medical Use Product Offerings
  • 7.9.5 Wanhua Chemical Recent Development

8 Industry Chain Analysis

• 8.1 Polycarbonate for Medical Use Industrial Chain
• 8.2 Polycarbonate for Medical Use Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Polycarbonate for Medical Use Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Polycarbonate for Medical Use Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer